Background: Nasal polyps (NPs) are one of the most common inflammatory mass lesions of the nose, affecting up to 0.5-4% of the population. The pathogenesis of NPs has been studied widely, but it is not clearly understood. A possible role of S. aureus in nasal polyposis has been suggested by numerous studies. This study aimed to map S.aureus colonisation in NP patients in the nose in comparison to healthy controls.
Material And Methods: We identified Staphylococcus aureus in nasal mucosal swab, collected from 58 patients with nasal polyposis from the out-patient ENT clinic of the Faculty Hospital in Nitra. We compared them to 50 patients without symptoms of nasal obstruction or NP. Isolated bacterial strains were then further identified.
Results: In nasal mucosa membrane, results were not statistically significant. The selected population consisted of 108 patients, of which 58 (54%) had nasal polyps and 50 (46%) didnt. We collected the following information about patients from both groups: age, gender, smoker, presence of asthma, allergy and presence of Staphylococcus aureus by cultivation from nasal mucosa. In addition, for patients with nasal polyposis we have following variables, such as: presence inflammatory diseases, allergy to acylpyrine, cystic fibrosis. Out of 58 patients with nasal polyposis 15% (n=9) were found to have S.aureus in nasal mucosa membrane, compared to the healthy controls where 6% (n=3) of patients had S. aureus.
Conclusion: Our results did not show that S. aureus found in nasal mucosa membrane is significantly different in patients with or without NP. However, association of the presence of S. aureus in patients with nasal polyposis with asthma, allergy and inflammation has been shown.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
GZMK-expressing CD8 T cells promote recurrent airway inflammatory diseases.
Nature
January 2025
Laboratory of Dynamic Immunobiology, Institute for Immunology, Tsinghua University, Beijing, China.
Inflammatory diseases are often chronic and recurrent, and current treatments do not typically remove underlying disease drivers. T cells participate in a wide range of inflammatory diseases such as psoriasis, Crohn's disease, oesophagitis and multiple sclerosis, and clonally expanded antigen-specific T cells may contribute to disease chronicity and recurrence, in part by forming persistent pathogenic memory. Chronic rhinosinusitis and asthma are inflammatory airway diseases that often present as comorbidities.
View Article and Find Full Text PDFLong-Term Effectiveness of Dupilumab in Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Multicenter Retrospective Study.
Am J Rhinol Allergy
January 2025
Otorhinolaryngology Head and Neck Surgery Department, IRCCS Arcispedale Santamaria Nuova, Reggio Emilia, Italy.
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a complex immunological disease associated with significant morbidity and reduced health-related quality of life. Dupilumab is an anti-T2-inflammatory biological drug registered for chronic rhinosinusitis with nasal polyps, indicated by integrated care pathways when optimal medico-surgical treatment yields insufficient control of sinonasal symptoms.
Objective: The purpose of this study was to confirm the long-term efficacy of dupilumab in the treatment of severe uncontrolled CRSwNP.
Actinomycosis masquerading as a nasal polyp - a rare entity and diagnostic challenge.
GMS Hyg Infect Control
December 2024
Department of ENT, Sree Balaji Medical college Chromepet, Chennai, Tamil Nadu, India.
Actinomycosis is an endogenous bacterial infection caused by . This bacterium reside on the mucosa of oral cavity, tonsils, and genitourinary tract. Any insult such as trauma, surgery, or foreign body disrupts the mucosal barrier and gives entry to the underlying tissue to cause disease.
View Article and Find Full Text PDFIncreased Incidence of Surgical Intervention for Otitis Media With Effusion Among Patients With Type 2 Inflammatory Diseases.
J Allergy Clin Immunol Pract
January 2025
Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa.
Background: Otitis media with effusion (OME) is associated with comorbidities such as allergic rhinitis, gastroesophageal reflux disease, asthma, and more. Many of these comorbidities can be caused by type 2 inflammation (T2I). This study aims to determine the risk of undergoing OME surgery in patients with and without T2I disease.
View Article and Find Full Text PDFAdvancing allergic rhinitis research through phenome-wide association studies: Insights from known genetic loci.
World Allergy Organ J
January 2025
Institute of Life Science, Chongqing Medical University, Chongqing, China.
Background: Allergic rhinitis (AR) is a common chronic respiratory disease that can lead to the development of various other conditions. Although genetic risk loci associated with AR have been reported, the connections between these loci and AR comorbidities or other diseases remain unclear.
Methods: This study conducted a phenome-wide association study (PheWAS) using known AR risk loci to explore the impact of known AR risk variants on a broad spectrum of phenotypes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!